Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
about
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?The Autoimmune EcologyAdvances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature ReviewSjögren's syndrome: still not fully understood diseaseTreatment of primary Sjögren syndrome.Characterization and risk estimate of cancer in patients with primary Sjögren syndromePain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients.Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndromeExpansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome Patients.Serologic features of primary Sjögren's syndrome: clinical and prognostic correlationPossible Mechanisms of Lymphoma Development in Sjögren's Syndrome.Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.The contribution of epigenetics in Sjögren's Syndrome.What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?Molecular genetic characterization of lymphoma: application to cytology diagnosis.Are the B cells cast with the leading part in the Sjogren's syndrome scenario?Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.Predicting progression to lymphoma in Sjögren's syndrome patients.Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.Update on Pathogenesis of Sjögren's syndrome.Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.Present and future of biologic drugs in primary Sjögren's syndrome.Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.Agranulocytosis and mixed-type autoimmune hemolytic anemia in primary sjögren's syndrome: a case report and review of the literature.The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndromePredictable biomarkers of developing lymphoma in patients with Sjögren syndrome: a nationwide population-based cohort study.Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.Polyangiitis with granulomatosis as a paraneoplastic syndrome of B-cell lymphoma of the lacrimal gland.Active immunological profile is associated with systemic Sjögren's syndrome.BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.Prognostic value of cryoglobulins, protein electrophoresis, and serum immunoglobulins for lymphoma development in patients with Sjögren's syndrome. A retrospective cohort study.Metabolomics analysis of saliva from patients with primary Sjögren's syndrome.Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome.
P2860
Q26739361-08839A07-D3CC-48FB-8A75-4C882909432FQ26747427-481D0CDB-D769-40A0-9452-1BBD1228DAA0Q26824039-C0DEB449-E271-4F9E-B785-A11E2C446BB0Q26851943-B0587EE5-208D-4B1D-954A-C385F7F6EABAQ30249011-B2B381C8-870B-4979-BC95-5E04BFB32354Q33568158-B5CA6681-65C1-47EC-A2AC-16D5C54BC3F1Q34065440-66859B92-C473-4A11-96F4-0F23125BD38AQ35130185-A56B74F2-D289-40F5-B61B-922C48AB0603Q35676007-BCCF336C-3A52-441F-B32B-ACBD8AFAE433Q35776056-1B137458-E121-4FD7-967C-48A1C052E14FQ35996410-927B0039-687B-4038-AEA0-6E9AB29EA5C1Q36700816-2D58ED7F-75B3-4F87-BDFC-7736F73427A4Q36998409-A8B98371-2566-447C-B6D3-6D008E8E9DD9Q37100264-B4342A4E-D847-4B22-8E61-2A0A82B5F168Q37205067-2FC63A7E-A56D-4B3F-808D-77AF32B48320Q37695272-B2939104-286E-409E-8237-C42EF11DBC5AQ37849356-093A3A28-286B-4888-B999-FCB20EBF1617Q37912214-8C30249A-4E5F-465D-9476-229190FD0590Q38012420-A13B7D98-C5D2-4424-9751-DFA0D6B04E60Q38120318-12728E54-C672-42D9-A2E4-AF532700EF8EQ38138170-F545BCF5-D9E5-4793-883C-59C0AA7010E5Q38180823-50602B34-350F-4DD0-822B-48F47624B416Q38217806-77EF3E4D-7C2E-4012-BA23-71B97530CFEFQ38559605-1F2959C4-6F48-41ED-B34A-D90F62BC356CQ38675817-81915CE7-0B37-4112-A253-30D23E909A62Q38822415-656BA932-D8A5-461C-B713-1764FA75A7F4Q38905170-EDF80278-02A3-4AD9-A7BD-A220DEF5F788Q39216694-0D09904D-3AB6-48C3-8C0C-2FA042822650Q39691687-CAEB7863-E594-496D-A6D4-8ECC2DFF21D9Q41259985-7A4EC7E8-3790-4635-8575-B1763E7613ADQ41472929-2DD81933-17D8-4D16-9AA2-898F1221C147Q41721609-DDCA1AA1-CFBF-42F6-8454-3E01AE8A7B63Q42473647-7724C9EF-CA0B-422B-AA84-0DFA195BAAC7Q42728473-3F9089FD-E1CA-4346-A137-0EEEA00EE9A1Q43545216-22EE5606-C019-4633-9E90-160F504B91E2Q44700638-2C49A324-940F-4990-82CF-CB2C96CD9D60Q46223982-EAE776BF-3B53-4050-902E-E0C27477B1A3Q47710355-0E4EABC9-2E26-4A96-8D39-C9A2CB462935Q51002642-43230C9F-9D65-430A-A831-A7294E447BB4Q51046403-00CD3ABF-8617-45B9-B4C8-464E6C5BABFF
P2860
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hematologic manifestations and ...... and pathophysiologic aspects.
@ast
Hematologic manifestations and ...... and pathophysiologic aspects.
@en
type
label
Hematologic manifestations and ...... and pathophysiologic aspects.
@ast
Hematologic manifestations and ...... and pathophysiologic aspects.
@en
prefLabel
Hematologic manifestations and ...... and pathophysiologic aspects.
@ast
Hematologic manifestations and ...... and pathophysiologic aspects.
@en
P2093
P1433
P1476
Hematologic manifestations and ...... and pathophysiologic aspects.
@en
P2093
Evangelia Baimpa
Haralampos M Moutsopoulos
Issa J Dahabreh
Michael Voulgarelis
P304
P356
10.1097/MD.0B013E3181B76AB5
P407
P577
2009-09-01T00:00:00Z